Get the latest Science News and Discoveries
Head-to-head trial shows Eli Lilly’s oral GLP-1 orforglipron outperforms oral semaglutide
A new trial found that Eli Lilly’s GLP-1 pill resulted in greater reductions in blood sugar levels and weight than oral semaglutide did, but fewer people stayed on it
None
Or read this on Scientific American
